Clinical Trial Update: Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males. [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of testosterone undecanoate in hypogonadal males.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: Abbott | Conditions: Hypogonadal Males | Phase 1 | Status: COMPLETED